ConductScience.org, home

Trial · NCT00824265

Adverse events486

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersOfatumumab + Fludarabine + Cyclophosphamide_ ITT Subjects24181
otherAnaemiaBlood and lymphatic system disordersFludarabine + Cyclophosphamide_ ITT Subjects38178
otherLeukopeniaBlood and lymphatic system disordersOfatumumab + Fludarabine + Cyclophosphamide_ ITT Subjects27181
otherLeukopeniaBlood and lymphatic system disordersFludarabine + Cyclophosphamide_ ITT Subjects10178
otherNeutropeniaBlood and lymphatic system disordersOfatumumab + Fludarabine + Cyclophosphamide_ ITT Subjects93181
otherNeutropeniaBlood and lymphatic system disordersFludarabine + Cyclophosphamide_ ITT Subjects62178
otherThrombocytopeniaBlood and lymphatic system disordersOfatumumab + Fludarabine + Cyclophosphamide_ ITT Subjects38181
otherThrombocytopeniaBlood and lymphatic system disordersFludarabine + Cyclophosphamide_ ITT Subjects55178
otherConstipationGastrointestinal disordersOfatumumab + Fludarabine + Cyclophosphamide_ ITT Subjects8181
otherConstipationGastrointestinal disordersFludarabine + Cyclophosphamide_ ITT Subjects11178
otherDiarrhoeaGastrointestinal disordersOfatumumab + Fludarabine + Cyclophosphamide_ ITT Subjects14181
otherDiarrhoeaGastrointestinal disordersFludarabine + Cyclophosphamide_ ITT Subjects19178
otherNauseaGastrointestinal disordersOfatumumab + Fludarabine + Cyclophosphamide_ ITT Subjects45181
otherNauseaGastrointestinal disordersFludarabine + Cyclophosphamide_ ITT Subjects36178
otherVomitingGastrointestinal disordersOfatumumab + Fludarabine + Cyclophosphamide_ ITT Subjects19181
otherVomitingGastrointestinal disordersFludarabine + Cyclophosphamide_ ITT Subjects22178
otherAstheniaGeneral disordersOfatumumab + Fludarabine + Cyclophosphamide_ ITT Subjects13181
otherAstheniaGeneral disordersFludarabine + Cyclophosphamide_ ITT Subjects16178
otherChillsGeneral disordersOfatumumab + Fludarabine + Cyclophosphamide_ ITT Subjects14181
otherChillsGeneral disordersFludarabine + Cyclophosphamide_ ITT Subjects3178

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00824265/events